Randomized Trial of Risk Information Formats in Direct-to-Consumer Prescription Drug Advertisements

@article{Aikin2011RandomizedTO,
  title={Randomized Trial of Risk Information Formats in Direct-to-Consumer Prescription Drug Advertisements},
  author={Kathryn J. Aikin and Amie C O'Donoghue and John L. Swasy and Helen W. Sullivan},
  journal={Medical Decision Making},
  year={2011},
  volume={31},
  pages={E23 - E33}
}
Background. Federal regulations specify that print advertisements for prescription drugs and biological products must provide a true statement of information “in brief summary” about each advertised product’s “side effects, contraindications, and effectiveness.” Some of the current approaches to fulfilling the brief summary requirement, although adequate from a regulatory perspective, result in ads that may be difficult to read and understand when used in consumer-directed promotion. Objective… 
Comparison of Brief Summary Formats Through a Health Literacy Lens
TLDR
Sponsors can employ a user-tested Health Literacy format to improve the understandability and usability of brief summaries with patients.
Communicating Benefit and Risk Information in Direct-to-Consumer Print Advertisements
TLDR
The study findings suggest that, for simple drug information, adding absolute frequencies and percentages to direct-to-consumer advertisements may benefit consumers.
Consumers' evaluation of brief summary formats of print direct‐to‐consumer advertisements
Purpose – The paper's aim is to measure the effect of various brief summary formats on consumers' drug‐related knowledge, evaluations of ad information, ad believability, attitudes towards the ad and
Placement and Format of Risk Information on Direct-to-Consumer Prescription Drug Websites
TLDR
The location of risk information on prescription drug websites can affect consumer knowledge of drug risks; however, signals and special formatting may not be necessary for websites to adequately inform consumers about drug risks.
The unintended consequences of argument dilution in direct-to-consumer drug advertisements
TLDR
It is shown that when commercials list severe side effects along with those that are most frequent, as required by the Food and Drug Administration, it dilutes consumers’ judgements of the overall severity of the side effects, which leads to greater attraction to those drugs.
A mixed-methods approach to assessing actual risk readership on branded drug websites
Despite FDA requirements that drug benefits and risks be presented in a ‘fair balance’ manner, little is known about the extent to which individuals actually seek and process risk information.
Are Disease Awareness Links on Prescription Drug Websites Misleading? A Randomized Study
TLDR
Compared with control participants, participants in link conditions were more likely to confuse disease information with drug benefits and to recall fewer true drug benefits, and disclosures did not diminish these effects, and exposure to disease information did not affect other perceptions or intentions.
Consumers' Optimism Bias and Responses to Risk Disclosures in Direct-to-Consumer (DTC) Prescription Drug Advertising: The Moderating Role of Subjective Health Literacy
type="main" xml:id="joca12028-abs-0001"> Despite a substantial body of research in direct-to-consumer advertising (DTCA) for prescription drugs, what is missing from the existing discussion on the
An Empirical Examination of the FDAAA-Mandated Toll-Free Statement for Consumer Reporting of Side Effects in Direct-to-Consumer Television Advertisements
TLDR
It is suggested that the toll-free statement can be added to DTC television advertisements without significantly affecting risk and benefit comprehension and that certain presentations are preferable for communicating the statement.
...
1
2
3
4
...

References

SHOWING 1-10 OF 19 REFERENCES
Using a Drug Facts Box to Communicate Drug Benefits and Harms Two Randomized Trials
TLDR
These randomized trials tested whether adding a drug facts box to consumer prescription advertisements improved consumer knowledge and judgment and helped consumers choose the superior drug.
The Drug Facts Box: Providing Consumers with Simple Tabular Data on Drug Benefit and Harm
TLDR
Most participants—even those with lower formal educational attainment—were able to understand and use the tabular data, and most participants were also able to use the table to make comparisons.
A New Model for Communicating Risk Information in Direct-to-Consumer Print Advertisements
Direct-to-consumer (DTC) pharmaceutical print ads are required by law to carry a “fair balance” of risks and benefits. There are little quantitative data on the effectiveness of risk communication to
Consumers'Attention to the Brief Summary in Print Direct-to-Consumer Advertisements: Perceived Usefulness in Patient–Physician Discussions
TLDR
Whether consumers attend to the brief summary of risk information in product-specific print direct-to-consumer advertisements and whether they find it useful in discussing the risks of taking the drug with their physicians is examined.
Direct-to-consumer advertising: developing evidence-based policy to improve retention and comprehension.
Pharmaceutical advertising was historically directed toward health care professionals and mainly communicated through medical journals. The arrival of direct-to-consumer advertising has sparked both
More effective nutrition label formats are not necessarily preferred.
Misleading tests of health behavior theories
  • N. Weinstein
  • Psychology
    Annals of behavioral medicine : a publication of the Society of Behavioral Medicine
  • 2007
TLDR
This article offers ideas for alternative testing strategies for cognitively oriented theories of health behavior based on correlational data that are not adequate for deciding whether a particular construct affects behavior or for testing one theory against another.
Suggestions for testing health behavior theories: Implications for mediator analysis
TLDR
Four types of data that can be collected around an ‘‘event’’ are referred to that would allow one to determine whether changes in perceptions predict subsequent changes in behavior, and this type of evidence may be as close as the authors are able to come to supporting the hypothesized mediational path.
The Role of Self-Efficacy in Achieving Health Behavior Change
TLDR
This review focuses on cigarette smoking, weight control, contraception, alcohol abuse and exercise behaviors, and suggests strong relationships between self-efficacy and health behavior change and maintenance.
...
1
2
...